Cargando…
Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an e...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303289/ https://www.ncbi.nlm.nih.gov/pubmed/28187752 http://dx.doi.org/10.1186/s12871-017-0316-4 |
_version_ | 1782506683245789184 |
---|---|
author | van der Zee, Esther N. Egal, Mohamud Gommers, Diederik Groeneveld, A. B. Johan |
author_facet | van der Zee, Esther N. Egal, Mohamud Gommers, Diederik Groeneveld, A. B. Johan |
author_sort | van der Zee, Esther N. |
collection | PubMed |
description | BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care. METHODS: We performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care. RESULTS: We found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334). CONCLUSIONS: The principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12871-017-0316-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5303289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53032892017-02-15 Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression van der Zee, Esther N. Egal, Mohamud Gommers, Diederik Groeneveld, A. B. Johan BMC Anesthesiol Research Article BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care. METHODS: We performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care. RESULTS: We found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334). CONCLUSIONS: The principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12871-017-0316-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-10 /pmc/articles/PMC5303289/ /pubmed/28187752 http://dx.doi.org/10.1186/s12871-017-0316-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article van der Zee, Esther N. Egal, Mohamud Gommers, Diederik Groeneveld, A. B. Johan Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title | Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title_full | Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title_fullStr | Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title_full_unstemmed | Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title_short | Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
title_sort | targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303289/ https://www.ncbi.nlm.nih.gov/pubmed/28187752 http://dx.doi.org/10.1186/s12871-017-0316-4 |
work_keys_str_mv | AT vanderzeeesthern targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression AT egalmohamud targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression AT gommersdiederik targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression AT groeneveldabjohan targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression |